The EPO published patent EP4200326A1 titled 'Hemostatic elastin-like polypeptides' filed by Universität Basel. The invention covers elastin-like polypeptide compositions (classified under C07K 14/78, C07K 7/08, C07K 14/75) with hemostatic applications (A61P 7/04). Inventors are Michael Nash and Ivan Urosev. The patent is designated for all 31 EPC contracting states including Germany, France, UK, Italy, Spain, and others.

This is a routine patent publication notice with no compliance obligations. Entities conducting research in elastin-like polypeptides or hemostatic agents should review this patent to assess potential freedom-to-operate implications. The publication date of March 25, 2026, marks the beginning of the opposition period during which third parties may challenge the patent's validity.